Atrial Fibrillation Clinical Trials in New York, New York

14 studies are recruiting for atrial fibrillation in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. The Fourth Left Atrial Appendage Occlusion Study

   LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cornell University for and on behalf of its Joan & Sanford I. Weill Medical College and The New York Presbyterian Hospital, New York, New York

   Locations

   150 in total

   Run by

   Hamilton Health Sciences Corporation

   See if you can join NCT05963698 on ClinicalTrials.gov

2. A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

   The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid he…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Lenox Hill Hospital, New York, New York

   Locations

   10 in total

   Run by

   Biosense Webster, Inc.

   See if you can join NCT07523750 on ClinicalTrials.gov

3. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

   REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in parti…

   Stage

   Phase 3

   Ages

   22 to 85

   Site

   NYU Langone Health, New York, New York

   Locations

   93 in total

   Run by

   Johns Hopkins University

   See if you can join NCT05836987 on ClinicalTrials.gov

4. Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

   Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and burden in clinical studies. However, lack of access to exercise programs has limited therapeutic ado…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06938412 on ClinicalTrials.gov

5. Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

   Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to large emboli which result in large cerebral vessel occlusion (LVO). This randomized control trial aims to address this unmet need by testing w…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Weill Cornell Medical Center, New York, New York

   Locations

   21 in total

   Run by

   Javelin Medical

   See if you can join NCT05723926 on ClinicalTrials.gov

6. PULSED AF Post-Approval Study

   PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Valley Hospital, New York, New York

   Locations

   23 in total

   Run by

   Medtronic Cardiac Ablation Solutions

   See if you can join NCT06578104 on ClinicalTrials.gov

7. A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

   A randomized, placebo-controlled, participant-and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden as well as the safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Weill Cornell Medical Center, New York, New York

   Locations

   40 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT07217067 on ClinicalTrials.gov

8. Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

   The primary objective of this clinical investigation is to demonstrate the safety and 12-month effectiveness of pulmonary vein isolation (PVI) and posterior LA wall isolation in the treatment of subjects with symptomatic paroxysmal and persistent atrial fibrillation using the pulsed field ablation …

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Montefiore Medical Center, New York, New York

   Locations

   6 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT06099730 on ClinicalTrials.gov

9. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

   The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Columbia University Medical Center, New York, New York

   Locations

   106 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT04045665 on ClinicalTrials.gov

10. Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction

    The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the battery longevity of the …

    Stage

    Not phased

    Ages

    18 and older

    Site

    Lenox Hill Hospital, New York, New York

    Locations

    6 in total

    Run by

    Northwell Health

    See if you can join NCT07638995 on ClinicalTrials.gov

11. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage

    Phase 3

    Ages

    18 and older

    Site

    Mount Sinai West, New York, New York

    Locations

    187 in total

    Run by

    Yale University

    See if you can join NCT03907046 on ClinicalTrials.gov

12. Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

    Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.

    Stage

    Not phased

    Ages

    21 and older

    Site

    Northwell Health, New York, New York

    Locations

    4 in total

    Run by

    Volta Medical

    See if you can join NCT06056271 on ClinicalTrials.gov

13. Pericardiotomy in Cardiac Surgery

    PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Weill Cornell Medicine, New York, New York

    Locations

    4 in total

    Run by

    Population Health Research Institute

    See if you can join NCT06486636 on ClinicalTrials.gov

14. CardioFocus HeartLight Post-Approval Study

    This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Mount Sinai Hospital, New York, New York

    Locations

    4 in total

    Run by

    CardioFocus

    See if you can join NCT03168659 on ClinicalTrials.gov